Search
nicotinamide riboside kinase 2; NRK 2; NmR-K 2; integrin beta-1-binding protein 3; muscle integrin-binding protein; MIBP; nicotinic acid riboside kinase 2; ribosylnicotinamide kinase 2; RNK 2; ribosylnicotinic acid kinase 2 (ITGB1BP3, NRK2, NMRK2)
Function:
1) cofactor biosynthesis; NAD+ biosynthesis
2) attenuates laminin matrix deposition & cell adhesion to laminin, but not to fibronectin
3) regulation of PXN & PXN tyrosine phosphorylation
4) regulation of terminal myogenesis
5) catalyzes synthesis of nicotinamide nucleotide from nicotinamide riboside
6) Preiss-Handler independent NAD biosynthesis.
7) interacts with ITGB1
ATP + N-ribosylnicotinamide = ADP + nicotinamide ribonucleotide
Kinetic parameters:
- KM=0.19 mM for nicotinamide riboside (with ATP as cosubstrate)
- KM=30 mM for nicotinamide riboside (with GTP as cosubstrate)
- KM=0.11 mM for tiazofurin (with ATP as cosubstrate)
- KM=0.063 mM for nicotinic acid riboside (with ATP as cosubstrate)
- KM=1.3 mM for uridine (with ATP as cosubstrate)
Structure:
- monomer (putative)
- belongs to the uridine kinase family, NRK subfamily
Alternative splicing: named isoforms=2
Expression:
- expressed predominantly in skeletal muscle
- expressed at a lower level in heart (at protein level)
- not expressed in brain, kidney, liver, lung, pancreas or placenta
- down-regulated during myoblast differentiation
General
kinase or ATP-phosphotransferase
Properties
SIZE: entity length = 230 aa
MW = 26 kD
MOTIF: ATP-binding site
NAME: ATP-binding site
SITE: 9-17
MOTIF: Mg+2-binding site
SITE: 16-16
aspartate residue {D35}
Mg+2-binding site
SITE: 35-35
binding site
SITE: 55-55
FOR-BINDING-OF: Substrate
kinase domain
MOTIF: ATP-binding site
NAME: ATP-binding site
ATP-binding site
NAME: ATP-binding site
SITE: 130-130
binding site
SITE: 131-131
FOR-BINDING-OF: Substrate
ATP-binding site
NAME: ATP-binding site
SITE: 134-134
Database Correlations
OMIM 608705
UniProt Q9NPI5
Entrez Gene 27231
Kegg hsa:27231
ENZYME correlations
References
UniProt :accession Q9NPI5